Cytrx Corp. (CYTR) Stock Price, Forecast & Analysis
USA - NASDAQ:CYTR -
CYTR Key Statistics, Chart & Performance
The current stock price of CYTR is 0.31 null. In the past month the price decreased by -39.29%. In the past year, price decreased by -76.87%.
CYTR Latest News, Press Relases and Analysis
About CYTR
Company Profile
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
Company Info
Cytrx Corp.
11726 SAN VICENTE BOULEVARD SUITE 650
LOS ANGELES CA 90049
CEO: Steven A. Kriegsman
Phone: 310-826-5648
Cytrx Corp. / CYTR FAQ
Can you describe the business of Cytrx Corp.?
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
What is the stock price of Cytrx Corp. today?
The current stock price of CYTR is 0.31 null. The price decreased by -18.38% in the last trading session.
Does Cytrx Corp. pay dividends?
CYTR does not pay a dividend.
What is the ChartMill rating of Cytrx Corp. stock?
CYTR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of Cytrx Corp. (CYTR) based on its PE ratio?
Cytrx Corp. (CYTR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
Can you provide the market cap for Cytrx Corp.?
Cytrx Corp. (CYTR) has a market capitalization of 10.43M null. This makes CYTR a Nano Cap stock.
CYTR Technical Analysis
CYTR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CYTR. CYTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CYTR Financial Highlights
Over the last trailing twelve months CYTR reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 80.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -4025.6% | ||
| ROA | -46.79% | ||
| ROE | -52.56% | ||
| Debt/Equity | 0 |